Ekkyo publishes positive results from its LASH treatment study

Dec 1 2009

A Multi-Center Clinical Study Started in 2007 Confirms That the Results of Physiological Scarring After Surgery can be Improved by Using the LASH(R) (Laser Assisted Skin Healing) Treatment. This New Therapeutic Approach is Based on the EkkyLite(TM) System and is the First Device to Improve Scarring. it has been Developed and is Sold by Ekkyo.

Ekkyo, a company specialized in photomedicine and dedicated to developing new systems to promote proper scarring, announced today the publication of new clinical results from a multi-center study started in 2007.

This clinical study has enabled validating the optimal dose, effectiveness and safety of the LASH(R) (Laser Assisted Skin Healing) treatment.

The study concerns 30 patients with phototypes I to IV on the Fitzpatrick scale who underwent surgery for abdominal repair. Each surgical incision was divided into two parts: one measuring 8 cm, which was treated once with a 810-nm diode laser right after the incision closure, and another, which was untreated. The treatment dose for each patient was between 80 and 130 J/cmsquared, depending on the patient's phototype.